Latest Articles

Improving Quality of Life in Patients with Uncontrolled Atopic Dermatitis (AD): Tools for Timely Identification and Treatment

Nirsevimab FAQs

RWE data on Nirsevimab and RSV preF vaccine

Real‑world evidence (RWE) provides valuable insights into the effectiveness, safety, and use of RSV preventive strategies beyond clinical trials. This data support informed decision‑making and optimize the implementation of RSV prevention strategies in real‑world settings

Saudi National immunization strategy for RSV prevention

Ensuring overall RSV prevention in every individual Dr. Alia Podcast

Factors Associated with Development of Atopic Comorbidities in AD

The soundbite recording captures Dr. Paller's discussion on factors that contribute to the development of atopic comorbidities in patients with atopic dermatitis. The presentation examines the relationship between AD and associated atopic conditions.

Can Early Intervention Shape the Course of Atopic Dermatitis

The soundbite recording captures Dr. Paller's discussion examining whether early therapeutic intervention can influence the natural course of atopic dermatitis. The presentation explores the potential for timely treatment approaches to modify disease trajectory.

Impact of Advanced Systemic Therapies on Disease Control in AD

This educational video features Dr. Eric Simpson's presentation on the Impact of Advanced Systemic Therapies on Disease Control in AD

Atopic Dermatitis in Children: High Burden and Limited Treatment Options

This educational video examines the prevalence of moderate and severe atopic dermatitis in children, presenting data that describes the significant disease burden and its impact on both pediatric patients and their families. The content explores current challenges in achieving optimal disease control in children with moderate and severe atopic dermatitis, providing healthcare professionals with evidence-based insights into the clinical management complexities of this patient population.